Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,244 | -33,376 | -26,745 | -19,601 | -11,040 |
| Depreciation Amortization | 158 | 621 | 527 | 367 | 190 |
| Other Working Capital | -1,403 | -5,430 | -5,233 | -3,351 | -2,511 |
| Other Operating Activity | 466 | -1,665 | -1,243 | -377 | -4 |
| Operating Cash Flow | $-8,023 | $-39,850 | $-32,694 | $-22,962 | $-13,365 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,892 | 43,411 | 42,337 | 24,381 | 13,588 |
| PPE Investments | 31 | 891 | 891 | 963 | 963 |
| Investing Cash Flow | $7,923 | $44,302 | $43,228 | $25,344 | $14,551 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | 19 | 14 | 14 | N/A |
| Financing Cash Flow | $6 | $19 | $14 | $14 | $N/A |
| Beginning Cash Position | 13,441 | 8,970 | 8,970 | 8,970 | 8,970 |
| End Cash Position | 13,347 | 13,441 | 19,518 | 11,366 | 10,156 |
| Net Cash Flow | $-94 | $4,471 | $10,548 | $2,396 | $1,186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,023 | -39,850 | -32,694 | -22,962 | -13,365 |
| Capital Expenditure | 31 | -72 | -72 | N/A | 963 |
| Free Cash Flow | -7,992 | -39,922 | -32,766 | -22,962 | -12,402 |